Data collected from lung cancer patients attending the Victoria Clinic
of the British Columbia Cancer Agency are used to investigate how res
ources are rationed in the treatment of non-small-cell lung cancer (NS
CLC). An ordered legit model is estimated to analyse empirically the r
elationship between treatment selection and: tumour stage, size and di
fferentiation; the Feinstein index; Karnofsky performance status (KPS)
; and the patient's age, gender and marital and smoking status. Implic
it rationing is found to occur with respect to all of these factors ex
cept the Feinstein index, gender and marital status. With respect to a
ge, KPS and smoker status the main empirical results are: (a) an incre
ase in age from 50 to 85 reduces the expected treatment expenditure by
50-70%, depending on the patient's KPS and smoker status; (b) patient
s with a KPS less than 80 and of 80, receive 30-46% and 75-85%, respec
tively, of the expected treatment expenditure for patients with a KPS
of 90 or 100, depending on age and smoker status; (c) the expected tre
atment expenditure for active smokers is about 71-86% of the expenditu
re for non- or former smokers depending on age and KPS.